SHERWIN STEPHEN A bought NBIX
May 27, 2026 · Form 4 insider transaction
SHERWIN STEPHEN A bought 2,567 shares of Neurocrine Biosciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,567
Price
$0.00
Total value
N/A
InsiderSHERWIN STEPHEN A
Role—
SecurityRestriced Stock Unit
Transaction codeA: Grant or award
Transaction dateMay 27, 2026
Filing dateMay 29, 2026
Shares owned after2,567
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock upon vesting.; The RSUs will vest in full on May 27, 2027.